Drosos E. Karageorgopoulos

10.4k citations

96 papers · 7.3k indexed · 2 hit papers · h-index 45

Impact in

Molecular Medicine top 0.05%
- Antibiotic Resistance in Bacteria
Applied Microbiology and Biotechnology top 0.1%
- Antibiotic Use and Resistance

Papers in

Molecular Medicine 33
- Antibiotic Resistance in Bacteria 33
Applied Microbiology and Biotechnology 7
- Antibiotic Use and Resistance 7

Co-authors: Matthew E. Falagas Anastasios Kapaskelis Evridiki K. Vouloumanou Petros I. Rafailidis George Samonis Antonia C. Kastoris Giannoula S. Tansarli M. E. Falagas
Journals: International Journal of Antimicrobial Agents (9 papers)European Journal of Clinical Microbiology & Infectious Diseases (8 papers)PLoS ONE (7 papers)Journal of Antimicrobial Chemotherapy (6 papers)Expert Review of Anti-infective Therapy (3 papers)
Partner nations: Greece United States China

In The Last Decade

Drosos E. Karageorgopoulos

95 papers receiving 7.0k citations

Hit Papers

align trajectories log scale

Deaths Attributable to Carbapenem-ResistantEnterobacteriaceaeInfections 2014 · 405 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2014 Emerging infectious diseases
2008 The FASEB Journal

Peers

Countries citing papers authored by Drosos E. Karageorgopoulos

Since Specialization

Citations

This map shows the geographic impact of Drosos E. Karageorgopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Drosos E. Karageorgopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Drosos E. Karageorgopoulos more than expected).

Fields of papers citing papers by Drosos E. Karageorgopoulos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Drosos E. Karageorgopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Drosos E. Karageorgopoulos. The network helps show where Drosos E. Karageorgopoulos may publish in the future.

Co-authors

The 25 scholars most cited alongside Drosos E. Karageorgopoulos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Drosos E. Karageorgopoulos Line = papers co-authored together Drosos E. Karageorgopoulos links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Resistance of Gram-Negative Bacteria to Eravacycline: A Systematic Review of Data from In Vitro Studies Pathogens ·Paola Robba, Philippe Jockey, 胡灵, Katie Harper, Drosos E. Karageorgopoulos	2025	0
2	Neuroimaging Findings in Racemose Neurocysticercosis: Case Description and Literature Review Habbab, Aikaterini Theodorou, 教文照井, Lina Palaiodimou, Matilda Papathanasiou, Panagiotis Toulas, Μαρία Θεοδωρακοπούλου, Maxime Pollet, Drosos E. Karageorgopoulos, Elisabeth Andreadou, Anastasios Bonakis, Konstantinos Voumvourakis, Georgios Tsivgoulis	2021	1
3	Emerging Treatment Options for Infections by Multidrug-Resistant Gram-Positive Microorganisms Microorganisms ·Despoina Koulenti, Builes Correa, MD R. Pointner, Rachel Bouvier, Drosos E. Karageorgopoulos, Apostolos Armaganidis, Sotirios Tsiodras, Jeffrey Lipman	2020	33
4	Severe Plasmodium vivax Malaria Complicated with Acute Respiratory Distress Syndrome: A Case Associated with Focal Autochthonous Transmission in Greece Vector-Borne and Zoonotic Diseases ·Shi Fakuan, Drosos E. Karageorgopoulos, Fokiya Akhtar, Nikolaos Melas, Leslie Meredith Wilson, T. Kohriki, Αndreas Μelidonis	2014	7
5	Incidence, Clinical, Microbiological Features and Outcome of Bloodstream Infections in Patients Undergoing Hemodialysis International Journal of Medical Sciences ·Gabriela Maia Oliveira, George Samonis, Antonis Valachis, Mildred Genevieve Louidor, Drosos E. Karageorgopoulos, Matthew E. Falagas, Kostas Stylianou, Diamantis P. Kofteridis	2013	68
6	Severe sepsis and septic shock due to Plasmodium vivax infection The American Journal of Emergency Medicine ·Athanasios Chalkias, Amanda Nunes Da Rosa, Drosos E. Karageorgopoulos, C. Cauffman, Jay N. Gbedd, You Bin Ha, Ouyang Qin, Sevda Altin, O. E. Adejumo, Theodoros Xanthos	2013	3
7	The Impact of Article Length on the Number of Future Citations: A Bibliometric Analysis of General Medicine Journals PLoS ONE ·Matthew E. Falagas, Angeliki Zarkali, Drosos E. Karageorgopoulos, Lê Tấn Thạnh, Michael N. Mavros	2013	110
8	Impact of antimicrobial multidrug resistance on inpatient care cost: an evaluation of the evidence Expert Review of Anti-infective Therapy ·Giannoula S. Tansarli, Drosos E. Karageorgopoulos, Anastasios Kapaskelis, Matthew E. Falagas	2013	78
9	Surveillance of Community Outbreaks of Respiratory Tract Infections Based on House-Call Visits in the Metropolitan Area of Athens, Greece PLoS ONE ·山口那津男, G. Ugueto, Drosos E. Karageorgopoulos, George Peppas, Dimitris Fouskakis, Matthew E. Falagas	2012	4
10	Stenotrophomonas maltophilia Infections in a General Hospital: Patient Characteristics, Antimicrobial Susceptibility, and Treatment Outcome PLoS ONE ·George Samonis, Drosos E. Karageorgopoulos, Sofia Maraki, Jefferson Moreira da Silva, Dimitra Dimopoulou, Nikolaos Spernovasilis, Diamantis P. Kofteridis, Matthew E. Falagas	2012	100
11	Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens Journal of Antimicrobial Chemotherapy ·Drosos E. Karageorgopoulos, Ruoying Wang, Yubing Liu, M. E. Falagas	2011	177
12	Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates European Journal of Clinical Microbiology & Infectious Diseases ·George Samonis, Sofia Maraki, Drosos E. Karageorgopoulos, Evridiki K. Vouloumanou, Matthew E. Falagas	2011	148
13	Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients International Journal of Antimicrobial Agents ·Matthew E. Falagas, Petros I. Rafailidis, Víctor Bazúl, Vangelis G. Alexiou, Dimitrios K. Matthaiou, Drosos E. Karageorgopoulos, Anastasios Kapaskelis, Dimitra Nikita, Argyris Michalopoulos	2009	244
14	Adjustment of dosing of antimicrobial agents for bodyweight in adults The Lancet ·Matthew E. Falagas, Drosos E. Karageorgopoulos	2009	109
15	Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies International Journal of Antimicrobial Agents ·Matthew E. Falagas, Antonia C. Kastoris, Drosos E. Karageorgopoulos, Petros I. Rafailidis	2009	145
16	Effect of body mass index on the outcome of infections: a systematic review Obesity Reviews ·Matthew E. Falagas, A.P. Athanasoulia, George Peppas, Drosos E. Karageorgopoulos	2009	101
17	Short- versus Long-Course Antibacterial Therapy for Community-Acquired Pneumonia Drugs ·George Dimοpoulos, Dimitrios K. Matthaiou, Drosos E. Karageorgopoulos, Alexandros Grammatikos, Zoe Athanassa, Matthew E. Falagas	2008	113
18	Tooth and Consequences The American Journal of Medicine ·Ioannis Melakopoulos, Drosos E. Karageorgopoulos, Christos Christodoulou, Dimosthenis Skarlos, Matthew E. Falagas	2008	1
19	Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence Journal of Antimicrobial Chemotherapy ·Drosos E. Karageorgopoulos, Theodoros Kelesidis, Iosif Kelesidis, Matthew E. Falagas	2008	166
20	Etiology of Anemia in Patients With Advanced Heart Failure Journal of the American College of Cardiology ·John N. Nanas, Charis Matsouka, Drosos E. Karageorgopoulos, D-W. Pang, Elias Tsolakis, Stavros G. Drakos, Eleftheria P. Tsagalou, Hemang Patel, George P. Alexopoulos, John Kanakakis, Maria Anastasiou‐Nana	2006	311

About Drosos E. Karageorgopoulos

Drosos E. Karageorgopoulos is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology, Pharmacology, Infectious Diseases and Epidemiology, having authored 96 papers that have together received 7.3k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (33 papers), Antibiotics Pharmacokinetics and Efficacy (26 papers), Pneumonia and Respiratory Infections (17 papers), Antimicrobial Resistance in Staphylococcus (12 papers), Urinary Tract Infections Management (11 papers), Antibiotic Use and Resistance (7 papers), Nosocomial Infections in ICU (5 papers) and scientometrics and bibliometrics research (5 papers). The work is most often cited by research in Molecular Medicine (3.2k citations), Applied Microbiology and Biotechnology (940 citations), Endocrinology (929 citations), Clinical Biochemistry (651 citations) and Pharmacology (1.5k citations). Drosos E. Karageorgopoulos has collaborated with scholars based in Greece, United States and China. Frequent co-authors include Matthew E. Falagas, Anastasios Kapaskelis, Evridiki K. Vouloumanou, Petros I. Rafailidis, George Samonis, Antonia C. Kastoris, Giannoula S. Tansarli, M. E. Falagas, Konstantinos Z. Vardakas and Dimitrios K. Matthaiou. Their work appears in journals such as International Journal of Antimicrobial Agents, European Journal of Clinical Microbiology & Infectious Diseases, PLoS ONE, Journal of Antimicrobial Chemotherapy and Expert Review of Anti-infective Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact